Herpes zoster vaccine awareness among people ≥ 50 years of age and its implications on immunization

Dermatology Online Journal

Volumn 18, Issue 8, 2012, Pages 2-

  Javed, Saba ^a   Javed, Fatima ^b   Mays, Rana M ^b   Tyring, Stephen K ^c,d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c Center for Clinical Studies   (United States)

^d University of Texas Health Science Center at Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; CHICKENPOX; DRUG APPROVAL; EDUCATIONAL STATUS; FEMALE; GENDER; HEALTH; HEALTH CARE COST; HERPES ZOSTER; HUMAN; IMMUNIZATION; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POSTHERPETIC NEURALGIA; RETIREMENT; VACCINATION;

AGE FACTORS; AGED; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HERPES ZOSTER VACCINE; HUMANS; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; SEX FACTORS; VACCINATION;

EID: 84865277234     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Tyring S, Moore AY, Lupi O (ed.): Mucocutaneous Manifestion of Viral. Disease 2nd edn: MPG Ltd; 2010.
2. Wiegering V, Schick J, Beer M, Weissbrich B, Gattenlohner S, Girschick HJ, Liese J, Schlegel PG, Eyrich M: Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis. BMC Pediatrics. 2011, 11:31. [PubMed]
3. Melish ME: Bullous varicella: its association with the staphylococcal scalded skin syndrome. The Journal of Pediatrics. 1973, 83(6):1019-1021. [PubMed]
4. Harpaz R, Ortega-Sanchez IR, Seward JF: Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports: Morbidity and Mortality Weekly Report. Recommendations and reports / Centers for Disease Control 2008, 57(RR-5):1-30; quiz CE32-34. [PubMed]
5. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE et al: A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. The New England Journal of Medicine. 2005, 352(22):2271-2284. [PubMed]
6. Mitka M: FDA approves shingles vaccine: herpes zoster vaccine targets older adults. JAMA: The Journal of the American Medical Association. 2006, 296(2):157-158. [PubMed]
7. U.S. Food and Drug Administration. (2011, March 24). FDA approves Zostavax vaccine to prevent shingles in individuals 50 to 59 years of age. News Release. Retrieved from http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm248390.htm.
8. Lu PJ, Euler GL, Harpaz R: Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008. American Journal of Preventive Medicine. 2011, 40(2):e1-6. [PubMed]
9. Lu P, Bridges CB, Euler GL, Singleton JA: Influenza vaccination of recommended adult populations, U.S., 1989-2005. Vaccine. 2008, 26(14):1786-1793. [PubMed]
10. Yawn BP, Wollan PC, Kurland MJ, St Sauver JL, Saddier P: Herpes zoster recurrences more frequent than previously reported. Mayo Clinic Proceedings. Mayo Clinic 2011, 86(2):88-93. [PubMed]
11. Donahue JG, Choo PW, Manson JE, Platt R: The incidence of herpes zoster. Archives of Internal Medicine. 1995, 155(15):1605-1609. [PubMed]
12. Mac Donald R, Baken L, Nelson A, Nichol KL: Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. American Journal of Preventive Medicine. 1999, 16(3):173-177. [PubMed]